Stay updated on Efficacy of LFG316 in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the Efficacy of LFG316 in PNH Patients Clinical Trial page.

Latest updates to the Efficacy of LFG316 in PNH Patients Clinical Trial page
- Check5 days agoChange DetectedThe page revision badge updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and the previous Revision: v3.4.1 text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding notice banner was added and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a glossary and a new study location Brno-Bohunice, Czech Republic, 625 00; updated metadata to Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the prior Brno Bohunice spelling and Revision: v3.3.4.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. No study information or user-facing details appear to be affected.SummaryDifference0.1%

- Check83 days agoChange DetectedLocations section consolidated into a single 'Locations' list including Czech Republic, Fukushima, Kanagawa, Osaka, and Tokyo. The page removes the separate country-location subsections and updates the revision to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Efficacy of LFG316 in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of LFG316 in PNH Patients Clinical Trial page.